ACADIA Pharmaceuticals Inc (NASDAQ:ACAD)

16.33
Delayed Data
As of Jun 22
 +0.38 / +2.38%
Today’s Change
14.51
Today|||52-Week Range
41.20
-45.77%
Year-to-Date

Today’s Trading

Previous close15.95
Today’s open16.01
Day’s range15.78 - 16.36
Volume13,523,005
Average volume (3 months)3,036,478
Market cap$2.4B
Data as of 4:00pm ET, 06/22/2018

Growth & Valuation

Earnings growth (last year)-0.85%
Earnings growth (this year)+28.92%
Earnings growth (next 5 years)-68.62%
Revenue growth (last year)+620.68%
P/E ratioNM
Price/Sales29.56
Price/Book7.10

Competitors

 Today’s
change
Today’s
% change
TAROTaro Pharmaceutical ...-1.36-1.14%
AKRXAkorn Inc+0.27+1.71%
----
MNKMallinckrodt Plc-0.17-0.87%
Data as of 4:02pm ET, 06/22/2018

Financials

Next reporting dateAugust 7, 2018
EPS forecast (this quarter)-$0.46
Annual revenue (last year)$124.9M
Annual profit (last year)-$289.4M
Net profit margin-231.71%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Stephen R. Davis
Executive VP, Chief Financial &
Accounting Officer
Todd S. Young
Corporate headquarters
San Diego, California

Forecasts